Key result
NAFLD in T2D linked to a ~21% coronary angioplasty prevalence compared to none without NAFLD.
Why the study?
Nonalcoholic fatty liver disease (NAFLD) is associated with increased cardiovascular risk, but factors linked to NAFLD and macroangiopathy prevalence in type 2 diabetes patients require further examination.
Is nonalcoholic fatty liver disease associated with increased prevalence of coronary angioplasty and altered lipid profiles in patients with type 2 diabetes?
Cross-Sectional (n=101)
Is nonalcoholic fatty liver disease associated with increased prevalence of coronary angioplasty and altered lipid profiles in patients with type 2 diabetes?
In patients with type 2 diabetes, the presence of NAFLD is associated with visceral obesity, lower HDL cholesterol, and a higher prevalence of coronary angioplasty.
Answers are grounded in this paper and cite their sources.
NAFLD may flag higher angioplasty risk in T2D; hypothesis-generating and should not yet change practice.
BACKGROUND: There is evidence that nonalcoholic fatty liver disease (NAFLD) is associated with increased cardiovascular risk. In this study we examined factors associated with the presence of NAFLD and the prevalence of macroangiopathy in patients with type 2 diabetes. MATERIAL AND METHODS: Subjects were 101 consecutive patients with type 2 diabetes: 72 with NAFLD and 29 free of NAFLD. NAFLD was diagnosed by ultrasonography. Serum lipids were measured enzymatically and glycated hemoglobin HbA1c was measured by HPLC. RESULTS: The mean age of patients was 53.1 ± 10.4 in the NAFLD group and 44.9 ± 10.9 years in patients without NAFLD (p<0.001). The mean duration of diabetes was 10 ± 6.3 years in patients with NAFLD and 15.1 ± 7.8 years in those without NAFLD (p<0.001). Mean values of glycated hemoglobin A1c were similar in both groups. Patients with NAFLD were characterized by a significantly higher prevalence of coronary angioplasty (20.8% vs. 0%, p=0.008). Overweight and obesity were observed in a higher percentage of patients with NAFLD (p<0.001). Patients with NAFLD were characterized by significantly higher values of alanine transaminase (p=0.033), and lower serum concentrations of HDL-cholesterol (p<0.001) and creatinine (p=0.034). Logistic regression analysis (p<0.001) revealed that NAFLD was positively associated with waist circumference above normal (women >80 cm, men >94 cm) (p=0.0083) and alanine transaminase activity (p=0.0164), and negatively with creatinine concentration (p=0.0226). In a second logistic regression model (p<0.001), waist circumference (p<0.007) and total cholesterol (p<0.008) were positive predictors, while HDL-C (p<0.003) was a negative predictor of NAFLD. CONCLUSIONS: The results of the study suggest that NAFLD is associated with visceral obesity and low HDL-cholesterol in patients with type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Barbara Idzior−Waluś (2013) conducted a cross-sectional in Type 2 diabetes (n=101). Nonalcoholic fatty liver disease (NAFLD) vs. No NAFLD was evaluated on Coronary angioplasty (p=0.008). Nonalcoholic fatty liver disease was associated with a higher prevalence of coronary angioplasty in patients with type 2 diabetes compared to those without NAFLD.
Synapse has enriched 10 related papers. Consider them for comparative context: